Abstract
Industrial enzymes are widely used in diverse applications, but low productivity limits their further widespread utilization. This research aimed to develop high-performance alkaline protease (AprE) expression strains of Bacillus licheniformis through element optimization and modular engineering. Firstly, the aprE gene expression cassette was systematically optimized through element engineering. To minimize host background interference, five large gene fragments were deleted from the genome of B. licheniformis DW2. This expression cassette and genome-reduced strain resulted in 5.77-, 4.84- and 1.31-fold increases in the activities of alkaline protease, nattokinase and chitinase, respectively. Crucially, metabolomics analysis then served as the pivotal discovery tool, revealing that high expression of AprE was constrained by insufficient precursor amino acids and excessive metabolic overflow. Subsequently, the amino acid biosynthesis, energy metabolism, overflow metabolism, and cell membrane/wall modules of the strain were successively modified. The final AprE expression host DM6E10 achieved a remarkable enzyme activity of 34,343 U/mL, with a maximum activity of 107,100 U/mL in a 5-L bioreactor. This study built an efficient cell factory for AprE production and provided insights for the optimization of other protein expression hosts.
Keywords: Bacillus licheniformis, Alkaline protease, Codon optimization, Genome reduction, Modular engineering, Energy metabolism
Abbreviations
- AprE
Alkaline protease
- UTR
Untranslated regions
- GRAVY
Grand average of hydropathicity
- SDS-PAGE
Sodium dodecyl sulfate - polyacrylamide gel electrophoresis
- GFP
Green fluorescent protein
- ATP
Adenosine triphosphate
- NK
Nattokinase
- GABA
γ-aminobutyric acid
- GC-MS
Gas chromatography mass spectrometry
- TCA cycle
Tricarboxylic acid cycle
- cyt c
cytochrome c
- PCA
Principal component analysis
- Acyl-CoA
Acyl coenzyme A
- FAS II
Type II fatty acid synthase system
- Acyl-ACP
Acyl-acyl carrier protein
- Acyl-P
Acyl phosphate
- LPA
Lysophosphatidic acid
- PA
Phosphatidic acid
- CDP-DAG
Cytidine diphosphate diacylglycerol
- PGP
Phosphatidylglycerol phosphate
- PG
Peptidoglycan
- CL
Cardiolipin
- CP
Carboxypeptidase
- LTA
Lipoteichoic acid
1. Introduction
Industrial enzymes are extensively utilized in diverse sectors, including the food industry, detergent formulations, and animal feed [1]. According to Grand View Research (2023), the global industrial enzyme market was valued at $7.53 billion in 2023 and is projected to reach $12.64 billion by 2033 [2]. Alkaline protease (AprE) boasts a multibillion-dollar market and is widely applied in biological detergents for low-temperature decontamination, eco-friendly leather processing, and food proteolytic hydrolysis. Besides, with the increasing global commitments to carbon neutrality, the replacement of conventional chemical manufacturing with enzymatic biocatalysis has emerged as an essential technological transition.
Efficient enzyme expression hinges on two critical elements, the enzyme and its expression host [3]. For enzyme engineering, strategies such as directed evolution, rational design and AI-assisted protein evolution have been shown to effectively enhance enzyme properties and produce commercially valuable proteins [[4], [5], [6]]. For instance, the G95P substitution obtained by error-prone PCR significantly enhanced both catalytic activity and stability of AprE from Bacillus clausii [5]. In host engineering, removing genes for competing products, nonessential proteins, or poorly characterized proteins can optimize the host genome and thus enhance recombinant protein expression [7].
Synthetic biology and metabolic engineering provide powerful approaches for constructing high-performance expression hosts. The optimization of codons [8] and expression elements, including promoters, UTRs, and pro-peptides [9], is crucial for constructing efficient gene expression cassettes. In addition, genome streamlining [10], deletion of competitive pathways [11], enhancement of precursor supply [12], and cell membrane and cell wall engineering [13] are beneficial for optimizing protein expression strains. While existing research has extensively explored individual modules affecting protein biosynthesis, it is crucial to further investigate the balance between the supply and consumption of precursors. Additionally, identifying the key limiting factors will provide guidance for targeted modifications of metabolic pathways.
Bacillus species, particularly Bacillus subtilis, Bacillus licheniformis and Bacillus amyloliquefaciens, are primary hosts for industrial enzyme production. Recently, efficient expression of various target proteins (e.g. α-amylases, protease, pullulanase) in B. subtilis has been achieved through engineering of expression elements and hosts [14,15]. Previously, modular engineering strategies implemented in B. amyloliquefaciens BAΔupp have been reported to enhance AprE production by 39.6% [16]. As a powerful and indispensable non-model microorganism for applied and industrial microbiology, B. licheniformis possesses advantageous features, including good secretory capacity, strong robustness, and simple genetic manipulation, making it a competitive host for industrial enzyme expression (e.g. alkaline proteases, nattokinase) [17,18]. However, the biological breeding and industrial application of B. licheniformis still face challenges, such as the unclear metabolic mechanisms and the imbalanced distribution of metabolic fluxes.
In this study, we aimed to systematically optimize B. licheniformis DW2 for protein expression, employing AprE from B. clausii as the reporter protein. The aprE gene expression cassette was first designed and optimized through element engineering. Subsequently, the DW2 genome was reducted to minimize the host background interference and obtain a universal expression host. Thereafter, the limiting factors of AprE high expression were identified based on metabolomic analysis. Finally, B. licheniformis DW2 was reconstructed through enhancing the supply of amino acids and energy precursors, modulating cell membrane and cell wall, and reducing overflow metabolism. Overall, this research not only established an efficient protein expression platform in B. licheniformis but also provided broadly applicable strategies for the development of other industrial enzyme chassis.
2. Material and methods
2.1. Strains and cultivation conditions
All strains used in this study were listed in Table S1. The plasmids and primers used in this study were presented in Table S2 and Table S3, respectively. E. coli DH5α was used for plasmid construction, and B. licheniformis DW2cas9n was used as the parental strain. Gene expression, knock-out, and integration vectors were constructed basing on the shuttle vector pHY300PLK and T2 (2)-Ori, respectively.
B. licheniformis and E. coli were grown on Luria-Bertani (LB) medium or in LB broth supplemented with antibiotics (tetracycline 20 μg/mL; kanamycin 20 μg/mL). AprE fermentation medium contained 50 g/L corn starch, 45 g/L soybean meal, 6 g/L CaCO3, 5 g/L (NH4)2SO4, and 0.35 g/L thermostable amylase. TB medium contained 12 g/L peptone, 24 g/L yeast extract, 5 g/L glycerol, 16.42 g/L K2HPO4, 2.31 g/L KH2PO4. The nattokinase fermentation medium consisted of 20 g/L glucose, 10 g/L peptone, 5 g/L yeast extract, 10 g/L NaCl, 10 g/L soy peptone, 10 g/L corn steep liquor, and 6 g/L (NH4)2SO4. The chitinase fermentation medium contained 50 g/L corn starch, 45 g/L soybean meal, 6 g/L CaCO3, and 5 g/L (NH4)2SO4. All cultures were maintained at 37°C unless otherwise stated.
2.2. Construction of recombinant strains
The construction of gene expression strains was referred to our previously reported method [19]. Plasmid pHY300PLK was used to construct a series of AprE expression vectors. The construction procedure of AprE expression vector pHY-P43-aprE served as an example, promoter P43 from B. licheniformis DW2, signal peptide of alkaline protease SPAprE and gene aprE from B. clausii were amplified by corresponding primers (Table S3), and then fused by splicing overlap extension (SOE)-PCR, and inserted into pHY300PLK using ClonExpress One Step Cloning Kit (Vazyme Biotech Co., Ltd, Nanjing, China), resulting in the plasmid pHY-P43-aprE. Besides, the double- and multi-mutant plasmids were constructed based on the plasmid pHY-P43-aprE. Then, these plasmids were transferred into B. licheniformis DM1 to obtain corresponding recombinant strains. Similarly, other protease and GFP expression strains were obtained with the same method.
Temperature-sensitive plasmid T2 (2)-Ori was used for constructing the gene integration and promoter replacement vectors. Taking vector T2-△oxdC as an example, the upstream and downstream homology arm of gene oxdC from B. licheniformis were amplified respectively, and after Splicing Overlap Extension (SOE)-PCR, they were assembled into T2 (2)-Ori vector, generating T2-△oxdC (Table S2). The generations of gene deletion, integration and promoter replacement strains were obtained as previous described [20].
CRISPR/Cas9n was conducted for the deletion of large segments from DW2 genome, and CRISPR/dCas9 was used for gene inference, and the relative methods were referred to the previous literature [21]. The gRNA expression plasmids were electroporated into B. licheniformis cells, and the deleted genes were verified by DNA sequencing.
2.3. Alkaline protease fermentation and enzyme activity detection
The recombinant strain of B. licheniformis was cultivated on LB agar plate for 12–14 h, and a single colony was first transferred to 5 mL LB medium, then scaled up to 20 mL to obtain the seed solution (OD600 ≈ 4.0). The seed culture was inoculated into 250 mL Erlenmeyer flask containing 20 mL AprE fermentation medium at a 5% inoculum dosage, and cultivated for 48 h to reach the fermentation end point (characterized by pH 8.3). Subsequently, the supernatant was obtained after centrifugation at 12,000 rpm for 10 min at 4°C, and then diluted serially. The AprE activity was detected using the Folin-Ciocalteu reagent according to Chinese National Standard GB/T 23,257-2009. One unit (U) of AprE activity was defined as the amount of enzyme producing 1 μg tyrosine per minute under specified conditions (40°C, pH10.5) through casein hydrolysis. The molecular mass of denatured recombinant protein was measured by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) with protein markers (Vazyme, China).
2.4. Methods for metabolomic analysis
Each AprE fermentation flask was rapidly cooled to 9 ± 2°C using liquid nitrogen to quench the cells. Cold 0.85% NaCl (v/v) was added to dilute the fermentation broth twice. After centrifugation at 1500 rpm at 4°C for 15 min, the supernatant was obtained. After centrifugation, the cells were washed with cold 0.85% NaCl and 2.5% (NH4)2CO3 using high-speed centrifugation (10,000 rpm) at 4°C for 5 min. The extraction procedure was carried out according to Yuan et al. [22]. Afterward, five OD600 units of cells were used for metabolites extraction and GC-MS analysis. GC-MS data were first converted into abf format using Reifycs Abf Converter (Analysis Base File), and the transformed data was matched with Fiehn Bin Base Metabolome Database using MSDIAL software, generating an output file designated as “Height file”. The peak area of each metabolite was normalized with internal standard (glycolipid concentrate mixture, Fatty acid methyl esters, C8–C30). The contents of intracellular organic carboxylic acid were analyzed according to the results of GC-MS. Subsequently, the processed data was subjected to principal component analysis (PCA). And SIMCA 14.1 (Umetrics, Sweden) was used to perform orthogonal partial least squares discriminant analysis (OPLS-DA). Metabolites with a VIP value > 1, p value < 0.05, and a fold change of >2 or <0.5 in each comparison were selected as differential metabolites. Analysis of differential metabolite's contributions to the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway was performed using MetaboAnalyst software (http://www.metaboanalyst.ca/MetaboAnalyst/). Finally, a heat map was generated using HemI (Heatmap Illustrator, http://hemi.biocuckoo.org/).
2.5. Methods of restriction codons analysis
First, the ideal proportion of codons (Ideal Prop., ‰; Table S6) was derived from the synonymous codon usage of B. licheniformis. We calculated the actual proportion of each codon (Codon Usage, ‰) within the exogenous aprE gene. Restriction codons were defined as those codons meeting both criteria based on our predetermined threshold criteria: (1) ideal proportion below 5‰ (in permillage, ‰), and (2) actual proportion exceedingly twice this ideal proportion.
2.6. Quantitative real-time PCR
The methods of RNA extraction and transcriptional level analysis were optimized based on previously described protocols [23]. Cells in middle log-phage were harvested for mRNA isolation, and RNA was extracted using the Bacterium Total RNA Extraction Kit (APEXBIO, China). The cDNA was produced using the HiScript®II Q RT SuperMix kit (Vazyme, China). Gene expression analysis of the target genes was performed using a CFX96 Real-Time PCR System (Bio-Rad, Hercules, CA, USA), and all assays were performed with three biological replicates with technical triplicates. The 16S rRNA gene was the reference gene, and the fold changes were calculated using 2−ΔΔCT method [24].
2.7. Analytical methods
Biomass was evaluated by measuring the absorbance at 600 nm (OD600) using a spectrophotometer (UV-160A; Shimadzu, Japan). Residual glucose was detected using biosensor analyzer (SBA 40C, Shandong Academy of Sciences, China) with an immobilized enzyme membrane. For measurements of free amino acid concentrations, samples were first centrifuged at 4000 rpm, 4°C for 5 min to remove solid precipitates from the medium, then centrifuge the supernatant at 12,000 rpm, 4°C for 10 min to obtain bacterial precipitates. The supernatant was derivatized according to the method described by Zhan et al. and subsequently analyzed by gas chromatography [25]. The concentrations of acetoin, 2, 3-butanediol and acetate were determined by gas chromatography according to Wang et al. [26]. The intracellular ATP concentration was determined by ATP assay Kit (Beyotime Biotechnology, China), according to its instruction manual. Established methods were applied for cell permeability and anion exchange capacity, as reported by Mo et al. [13]. The net charge and isoelectric point of signal peptide were calculated using an online tools – peptide property calculator (https://www.novopro.cn/tools/calc_peptide_property.html). Nattokinase activity was measured by fibrin degradation [27]. The chitinase activity was determined by DNS method using colloidal chitin as the substrate [28].
2.8. AprE production in 5 L bioreactor
For AprE production in a 5 L bioreactor, B. licheniformis strain was cultivated in 2.5 L AprE production medium. The AprE production medium contained 30 g/L glucose, 40 g/L corn pulp, 15 g/L yeast extract, 5 g/L (NH4)2SO4, 1 g/L MgSO4, 6 g/L CaCO3 and 1 g/L K2HPO4. The fermentation parameters were as follows: the inoculum volume was 10%, with antibiotics added at 3‰. The pH was controlled at 7.0 throughout the fermentation. The initial aeration rate was 2 L/min, increasing to a maximum of 7 L/min. The initial agitation rate was 200 rpm, with a maximum of 800 rpm. The dissolved oxygen was kept at 25% ± 5% by adjusting agitation rate and aeration.
For fed-batch fermentation, the initial glucose concentration was reduced to 30 g/L, 10 g/L Glucose was added when the glucose concentration fell below 10 g/L and the cell wet weight was less than 90. When the cell wet weight exceeded 90, a total of 200 g corn starch was added. The feed of nitrogen source was to fill 50 g corn pulp with distilled water to 150 mL, after sterilization, and to make a one-time supplement at the 12 h and 24 h of fermentation respectively.
2.9. Statistical analysis
All samples were analyzed in triplicate, and the data were presented as the mean ± the standard deviation for each sample point. Data analysis was done using one-way analysis of variance (ANOVA) and Duncan's multiple range using SPSS® 19.0 at P ≤ 0.05.
3. Results
3.1. Optimization of expression cassettes via element engineering
3.1.1. Codon optimization of aprE based on comparative analysis
To optimize the codons of aprE gene, we calculated the actual proportion of each codon, accounting for differences in codon usage bias between the phylogenetically close microorganisms B. licheniformis and B. clausii (Tables S4–S6). This study identified codons potentially limiting aprE expression in B. licheniformis, including proline codon CCA, leucine codon CUA, and serine codon AGU. Subsequently, these codons were replaced with preferred synonymous codons, and the resulting 18 mutants were constructed and expressed in strain DM1 (DW2cas9n△M44) (Fig. 1a). The results of activity assays revealed that mutants P97CCG, P116CCG, S234TCG and S241TCG exhibited increased activity compared to control strain DM1/aprE (CK), with enhancements of 22.02%, 18.08%, 17.87% and 13.71%, respectively (Fig. 1a). Conversely, the activities of mutants S21TCG, P162CCG and P306CCG were significantly decreased by 18.59%, 18.91% and 58.14%, respectively. Enzyme activity changes at the remaining sites were not statistically significant.
Fig. 1.
Effects of element optimization on AprE expression. a: Activities of codon signal-point mutants. b: Activities of codon multi-point mutants. c: The relative transcriptional level of aprE in codon mutant strains. d: AprE activities of promoter mutants. e: The relative transcriptional level of aprE mediated by different promoters. f: AprE activities of signal peptide mutants. g: Isoelectric point (pI) and GRAVY values of signal peptide mutants. h: AprE activity change curves of the mutants P4K-A13L and CK. i: SDS-PAGE analysis of mutants P4K-A13L and CK. The red arrow indicates AprE, lane 1, 36 h-CK; Lane 2, 36 h P4K-A13L; Lane 3, 39 h-CK; Lane 4, 39 h P4K-A13L; Lane 5, 42 h-CK; Lane 6, 42h P4K-A13L; Lane 7, 45h-CK; Lane 8, 45h P4K-A13L; M, protein Marker. Data are represented as the means of three replicates, and error bars represent the standard deviations. *, P < 0.05; **, P < 0.01; ***, P < 0.001 indicate the significance levels between control and its mutant strains.
Subsequently, the favorable mutation sites P97CCG, P116CCG, S234TCG and S241TCG were combined. Among the six double-mutant constructs generated, P97CCG-P116CCG exhibited the highest activity, representing a 28.40% increase over the control strain DM1/aprE (CK) (Fig. 1b). The triple-mutant P97CCG-S241TCG-P116CCG also demonstrated enhanced activity, achieving a 32.11% increase compared to CK. Furthermore, RT-qPCR analysis revealed that transcriptional level of gene aprE progressively decreased with the serial combination of optimized codons, culminating in a significant 28.50% reduction in triple-mutant strain compared to control (Fig. 1c). We indicated that the optimized codons may have influenced the transcriptional level of genes by introducing secondary structures or triggering other physiological activities. However, the substitution of restrictive codons may also have reduced the retention of ribosomes on mRNA, enhancing translation efficiency, and the specific mechanism still requires further investigation.
3.1.2. Promoter engineering of the aprE gene
To further optimize the expression cassette, we evaluated four promoters (P43, PykzAPrbs6, PR55 and PR39) previously constructed in our laboratory for aprE expression [29]. The results of AprE activity demonstrated that PykzAPrbs6 exhibited the best performance, AprE activity driven by which was increased by 16.06% compared to P43, achieving 7595 ± 309 U/mL (Fig. 1d), and RT-qPCR analysis revealed that the transcriptional level of aprE mediated by PykzAPrbs6 was 79.51% higher than that of P43 (Fig. 1e). Interestingly, while stronger promoters like PR55 further increased transcription levels, they resulted in moderate decreases in recombinant protein expression, suggesting potential bottlenecks in translation, protein folding, or secretion processes.
3.1.3. Enhancing secretion through optimizing the tripartite structure of signal peptide
To improve the secretion efficiency of AprE, we analyzed the tripartite structural characteristics (N-, H-, C- regions) of native Sec-type signal peptide SPAprE. Based on the expression cassette PykzAPrbs6-SPAprE-aprE, seven SPAprE mutants were constructed, and AprE activity of mutant P4K was increased by 22.16%, compared with the original signal peptide strains (DM1/PykzAPrbs6-SPAprE-aprE), and dominant mutant P4K-A13L further enhanced performance, achieving an activity of 10,471 ± 444 U/mL, increased by 37.86% (Fig. 1f). Biophysical characterization showed that the optimized signal peptide P4K-A13L exhibited an increased net positive charge (from +3.0 to +4.0 at pH 7.0) and a higher GRAVY value (grand average of hydropathicity, from 1.03 to 1.19), which increased the hydrophobicity of signal peptide (Fig. 1g). Fermentation profiling confirmed that AprE activity and extracellular protein content of optimal mutant P4K-A13L were significantly higher than controls throughout the whole fermentation process (Fig. 1h–i). Therefore, through codon optimization and element engineering, we obtained a superior expression cassette PykzAPrbs6-SPAprE-P4K-A13L-aprEP97-S241-P116.
3.2. Construction of enzyme-expression chassis of B. licheniformis DW2 through genome streamlining
3.2.1. Effect of large fragment deletion on AprE expression
Excessive genomic redundancy can impair gene expression and product synthesis [30]. In this study, based on the genome sequencing results of DW2, we selected five large gene fragments, screened redundant genes, and studied their influence on AprE expression (Table S6). The deletion of fragments M44, M19, M28, M15, and M58 from DM0 (DW2cas9n) was conducive to AprE expression, and their deletion had no obvious effects on cell growth (Fig. 2a–b). Specifically, M44, M15, and M58 encode proteins involved in the synthesis of competitive metabolites—bacitracin, lichenysin, and poly γ-glutamic acid (γ-PGA), respectively. M19 corresponds to a prophage region gene island, while the M28 region, located at positions 350,347-370,441, comprises a complex set of genes (Table S7). Notably, the deletion of M28 led to the most substantial enhancement in AprE activity (Fig. 2b).
Fig. 2.
Effect of genome reduction on protein expression. a: Schematic illustration of genome reduction. b: AprE activities and biomass of large fragment deletion strains. c: AprE activities and biomass of large fragment superposition deletion strains. d: Nattokinase activities of strains DM0/NK, DM0/NK* and DM5/NK*. e: Chitinase activities of strains DM0/ChiT, DM0/ChiT* and DM5/ChiT*. Data are represented as the means of three replicates and error bars represent the standard deviations. *, P < 0.05; **, P < 0.01; ***, P < 0.001 indicate the significance levels between control and its mutant strains.
Superimposed deletion of fragments M44, M19, M28, M15, and M58 generated derivative strains DM1, DM2, DM3, DM4, and DM5, and then the optimized expression vector pHY-PykzAPrbs6-SPAprE-P4K-A13L-aprEP97-S241-P116 (denoted as E*) was electroporated into these strains (Fig. 2c). Specifically, as multiple fragments were sequentially deleted, AprE activity gradually increased, and strain DM5/E* achieved an activity of 22,295 ± 1580 U/mL, representing a 1.99-fold increase over DM0/E* (Fig. 2c), and a 5.77-fold increase compared to DM0/E. Furthermore, DM5/E* exhibited higher biomass, after 24 h fermentation in TB medium, its biomass (6.49 ± 0.14) was 7.27% higher than that of DM0/E* (6.05 ± 0.08) (Fig. 2c).
Subsequently, the preferred expression element and the genome reducted host DM5 exhibited excellent performance in producing alikaline protease, nattokinase (NK) from B. subtilis and chitinase (ChiT) from Caldicellulosiruptor acetigenus. First, the original elements (promoters and signal peptides) were replaced with preferred expression element combination PykzAPrbs6-SPAprE-P4K-A13L, and then the resulting plasmids pHY-PykzAPrbs6-SPaprE-P4K-A13L-NK (abbreviated as NK*) and pHY-PykzAPrbs6-SPaprE-P4K-A13L-ChiT (ChiT*) were electroporated into the DM0 strain, the enzyme activities of DM0/NK* and DM0/ChiT* were increased by 29.50% and 29.74%, respectively (Fig. 2d–e). Furthermore, the optimized vectors were transferred into genome-reducted host DM5, and the enzyme activities of DM5/NK* and DM5/ChiT* were increased by 351.09% and 78.37%, respectively, compared to the controls DM0/NK* and DM0/ChiT* (Fig. 2d–e). These results also indicated that the combined use of expression elements and the reducted host DM5 provides an effective platform for enhancing the secretory expression of diverse industrial enzymes.
3.3. Metabolomics-assisted analysis of the limiting factors on AprE production
3.3.1. Metabolomics analysis of AprE strains with differential expression level
The amino acid composition analysis revealed that branched-chain amino acids (BCAAs) constitute the main components of AprE. Gene bcd, encoding leucine dehydrogenase, is responsible for the degradation of BCAAs, so bcd was deleted from DM5 to redirect metabolic flux toward BCAA biosynthesis, attaining strain DM6. The AprE expression strain DM6/E* was constructed simultaneously. As shown in Fig. 3, AprE activity of DM6/E* was 22,408 ± 562 U/mL, which was 2.00% higher, and the valine concentration of DM6/E* was increased by 64.90% to 5.87 ± 0.22 mg/L, compared to DM5/E* (3.57 ± 0.14 mg/L) (Fig. 3b). The marginal improvement in enzyme activity despite substantial valine accumulation suggests the existence of rate-limiting bottlenecks beyond precursor availability.
Fig. 3.
Metabolomics analysis of customized AprE expression chassis. a: AprE activities of DM5/E* and DM6/E*. b: The amino acid concentrations of DM5/E* and DM6/E*. c: AprE activities of DM6E and DM6E/E*. d: Differential metabolic pathways. e: Differential metabolites. f: Schematic illustration of the limiting factors. Data are represented as the means of three replicates and error bars represent the standard deviations. *, P < 0.05; **, P < 0.01; ***, P < 0.001 indicate the significance levels between control and its mutant strains.
Consequently, customized hosts with differential AprE expression levels were constructed for metabolomic analysis. The AprE expression cassette PykzAPrbs6-SPAprE-aprE was integrated into the DM6 genome to generate DM6E. Strain DM6E/E* was obtained by transferring pHY-PykzAPrbs6-SPAprE-P4K-A13L-aprEP97-S241-P116, into DM6E. Their AprE activities were 15,232 ± 325 U/mL and 35,494 ± 547 U/mL, respectively (Fig. 3c). Furthermore, a metabolomic analysis of DM6E and DM6E/E* was performed, which quantitatively profiled a total of 53 metabolites. Seven differential metabolites was identified through SIMCA analysis; notably, the threonine content in DM6E/E* was significantly decreased compared to the control, while the remaining six metabolites exhibited increases (Table 1). Additionally, the coordinated accumulation of amino acid precursors (valine, isoleucine, tyrosine, and glutamate) and the energy carrier (pyrophosphate) suggested adaptive metabolic remodeling that supports high-level AprE expression (Fig. 3e–Table 1). Specifically, the concentrations of overflow metabolites in central carbon metabolism, including glycolic acid, ethanolamine and oxalic acid, were relatively higher (Table S8). These results indicate that insufficient precursor amino acids and excessive metabolic overflow are critical limitations for achieving high levels of AprE production (Fig. 3f).
Table 1.
Differential metabolites of strains DM6E and DM6E/E*.
| Metabolites | KEGG | DM6E ave | DM6E/E* ave | p-value | (DM6E/E*)/DM6E |
|---|---|---|---|---|---|
| Threonine | C00188 | 4.966 ± 2.686 | 1.953 ± 1.368 | 4.23E-02 | 0.393 |
| Lactose | C00243 | 2.278 ± 0.777 | 4.731 ± 1.379 | 5.42E-03 | 2.077 |
| Tyrosine | C00082 | 2.280 ± 1.008 | 5.015 ± 2.461 | 4.16E-02 | 2.200 |
| Isoleucine | C00407 | 21.959 ± 19.843 | 66.244 ± 35.168 | 2.80E-02 | 3.017 |
| Glutamic acid | C00025 | 5.205 ± 5.502 | 26.740 ± 18.579 | 3.53E-02 | 5.137 |
| Valine | C00183 | 1.426 ± 1.691 | 9.447 ± 6.317 | 2.53E-02 | 6.626 |
| Pyrophosphate | C00013 | 0.357 ± 0.799 | 2.392 ± 1.850 | 4.35E-02 | 6.705 |
3.3.2. Optimization of the supply of amino acid precursors for AprE synthesis in DM6E
To address limitations in precursor amino acid availability, glycine, serine, threonine, and valine with final concentrations of 0.03 g/L were added separately into medium at 24 h. Fermentation results revealed that glycine supplementation significantly enhanced AprE activity, whereas supplementation with other amino acids had negligible effects (Fig. 4a). Integrating these findings with the biosynthetic pathways of the respective amino acids (Fig. 4b), we sequentially engineered the strain by overexpressing serA, ysaA, serC, glyA, and folD, and by deleting thiO. The overexpression was achieved by promoter engineering, wherein the native promoters of serA, ysaA, and folD were replaced with Pbay, while those of serC and glyA were substituted with P43U12 and PylB, respectively.
Fig. 4.
Optimization of precursor amino acids supply for AprE expression. a: Effect of amino acid addition on AprE activity of DM6E. b: Relative concentrations of intracellular metabolites in DM6E and DM6E/E*. The ratios of each metabolite in the strains DM6E/E* and DM6E are represented by varying colors, with the different metabolites marked with *. Genes in the amino acid biosynthesis module are marked in red, and those in the central carbon metabolism module are highlighted in green. c: Effect of amino acid synthesis pathway modification on AprE activity. d: Intracellular concentrations of amino acid. e: The relative contents of oxalic acid, glycolate and glycine of DM6E and DM6E/E*. f: Acetate concentrations. g: Relative transcription levels of aceB and aceA in DM6E7 and DM6E7-aceBTA. h: AprE activities of reduced overflow metabolism engineering strains in AprE fermentation medium. i: AprE activities in TB medium. Data are represented as the means of three replicates and error bars represent the standard deviations. *, P < 0.05; **, P < 0.01; ***, P < 0.001 indicate the significance levels between control and its mutant strains.
Fermentation analysis showed that AprE activity of strain DM6E-PylB-glyA (DM6E1) reached 18,665 ± 276 U/mL, which was a 14.17% increase over the control strain DM6E (Fig. 4c). Meanwhile, the intracellular glycine content of DM6E1 achieved a 25.75% elevation (Fig. 4d), suggesting that glyA overexpression enhances glycine availability and thereby boosts AprE activity. This enhancement may be attributed to improved cell membrane/wall permeability, and increased thermal stability of the target protein [31]. While other genetic modifications similarly elevated amino acid content, their corresponding improvements in AprE activity were less pronounced (Fig. 4c–d). Although glycine did not show significant changes in metabolomic profiles, it conferred a notable phenotype of increased enzyme activity. This may be attributable to its central position in the metabolic network and its involvement in multiple pathways—it functions not only as a fundamental amino acid for protein synthesis, but also as a key methyl donor in purine and thymidylate biosynthesis, and as a precursor for glutathione and heme production [32]. Therefore, even if its steady - state concentration does not decline markedly (possibly due to rapid compensatory endogenous synthesis or buffering by a large metabolic pool), restricted flux through this hub can still exert widespread effects on cellular physiology.
3.3.3. Effect of reducing the central metabolism overflow of DM6E strain on AprE expression
Given the elevated intracellular concentrations of glycolic acid and acetate (Fig. 4e) in the AprE high-expressing strain DM6E/E*, we systematically evaluated multiple metabolic interventions to reduce the accumulation of organic carboxylic acids, including formate, acetate, oxalate and glyoxylate.
Regarding formate synthesis, genes pflB and yrhE were deleted from strain DM6E, and AprE activity of strains DM6E△pflB and DM6E△yrhE did not increase significantly (Fig. 4f). Concerning acetate synthesis, where pyruvate oxidase YdaP catalyzes the conversion of pyruvate to acetylphosphate [33], and its deletion strain DM6E△ydaP exhibited a 7.15% improvement in AprE activity over the control (Fig. 4g). For oxalate metabolism, deletion of oxalate decarboxylase gene oxdC generated strain DM6E△oxdC, which exhibited an AprE activity of 18,327 ± 681 U/mL and was 12.10% higher than DM6E (Fig. 4h). Regarding glyoxylate cycle regulation, we downregulated aceA transcription via λt0 terminator insertion in aceB-aceA operon and enhanced glcDF expression by replacing its native promoter with the strong promoter PbacA (Fig. 4f–i). To identify strategies that mitigate intermediate overflow, recombinant strains were fermented in TB medium supplemented with 20 g/L glucose. Under these conditions, AprE activities of DM6E-AceBTA and DM6E-PbacA-glcDF reached 4444 ± 231 U/mL and 4168 ± 245 U/mL, which were 1.80 and 1.11 times higher than that of control strain DM6E, respectively (Fig. 4i).
3.4. Modular optimization of AprE expression strains
3.4.1. Effect of energy supply pathway modification on the AprE-expressing strain DM6E1
Energy supply constraints emerged in high-yield AprE strains, as evidenced by a 27.66% reduction in ATP concentration in DM6E/E* compared to DM6E (Fig. 5a). Given the relatively high pyrophosphate level in DM6E/E*, we speculate that energy supply is limited in these strains. Consequently, the energy metabolism module was modified and optimized.
Fig. 5.
Effect of energy supply pathway modification of DM6E1 strain on AprE expression. a: ATP concentrations of DM6E and DM6E/E*. b: AprE activities. c: ATP concentrations. d: The modification of strains DM6E1-P43U12-ndk. e: Schematic illustration of energy supply module. Data are represented as the means of three replicates and error bars represent the standard deviations. *, P < 0.05; **, P < 0.01; ***, P < 0.001 indicate the significance levels between control and its mutant strains.
Through replacing the native promoter of nucleoside diphosphate kinase gene ndk by promoter P43U12 in DM6E1, the activity of DM6E1-P43U12-ndk increased to 22,802 ± 792 U/mL, which is approximately 22.16% higher than that of DM6E1 (Fig. 5b), and ATP concentration per unit cell increased 3.83-fold, from 0.03 ± 0.01 to 0.17 ± 0.01 μmol (Fig. 5c). Although strengthening adenylate kinase gene (adk) expression and deleting cytochrome bd complex gene cydB also improved AprE expression, the effects were weaker than that of ndk overexpression (Fig. 5b). Hence, DM6E1-P43U12-ndk was chosen for further modification.
3.4.2. Improving the performance of strain DM6E2 through cell membrane and cell wall engineering
Cell membrane and cell wall engineering, via directional modification of key components and surface proteins, can optimize strain functionality or confer new characteristics, such as material exchange, cell respiration and growth, while also influencing protein maturation and secretion [34]. This study implemented cell membrane and cell wall engineering of the AprE-producing strain from three perspectives, which are, enhancing membrane proteins involved in protein folding, optimizing cell wall synthesis and modification, and delaying cell autolysis.
Firstly, we initially screened PrsA chaperones from B. licheniformis, B. subtilis, and B. clausii, designated PrsAbl, PrsAbs, and PrsAbc, respectively. These membrane-associated chaperones exert crucial functions in facilitating the folding and extracellular secretion of heterologous proteins. Among the strains overexpressing these PrsA variants, DM7E2/pHY-prsAbs exhibited the highest AprE activity, followed by DM7E2/pHY-prsAbc and DM7E2/pHY-prsAbl. The AprE activity of DM7E2/pHY-prsAbs reached 20,851 ± 909 U/mL, which was 18.42% higher than that of the control strain DM7E2/pHY (17,608 ± 1199 U/mL) (Fig. 6a). Therefore, we selected prsAbs for further engineering. It was expressed under the control of P43U12 promoter and integrated into the nagB1 locus of DM6E2. The resulting engineered strain DM6E3 (DM6E2-nagB1P43U12-prsAbs) showed an even higher AprE activity of 23,867 ± 716 U/mL, which represented a 4.67% increase compared to DM6E2 (Fig. 6b).
Fig. 6.
Effect of cell membrane and wall engineering on AprE expression. a: Effect of PrsA overexpression on AprE expression. b: Effect of PrsAbs integration on AprE expression. c: Schematic of cell membrane and cell wall biosynthesis. Acyl-CoA, Acyl coenzyme A; FAS II, type II fatty acid synthase system; Acyl-ACP, Acyl-acyl carrier protein; Acyl-P, Acyl phosphate; LPA: Lysophosphatidic acid; PA, phosphatidic acid; CDP-DAG: Cytidine diphosphate diacylglycerol; PGP, Phosphatidylglycerol phosphate; PG, peptidoglycan; CL, Cardiolipin; CP, Carboxypeptidase; LTA, Lipoteichoic acid. d: AprE activities of cell membrane and cell wall engineered strains. e: AprE activities of DM6E2, DM6E2-△ydaPfabHB and DM6E2△lytD. f: Growth curve. Data are represented as the means of three replicates and error bars represent the standard deviations. *, P < 0.05; **, P < 0.01; ***, P < 0.001 indicate the significance levels between control and its mutant strains.
Subsequently, we designed a series of modification strategies to optimize cell wall synthesis and modification. These strategies included enhancing the expression of acetyl-CoA supply genes mmgA and fabN [35], enhancing the expression of teichoic acid synthesis genes plsX and plsC, and deleting peptidoglycan synthesis bypass pathway genes pssA, clsA, dacA and dltB (Fig. 6c). Fermentation results showed that deletion of pssA increased AprE activity by 8.02%, while enhancement of plsC expression in DM6E2 increased AprE activity by 7.33% (Fig. 6d). The AprE activities of strains DM6E2△dltB, DM6E2-Pbay-plsX, DM6E2△clsA and DM6E2△dacA were all significantly lower than that of DM6E2, whereas the remaining engineered strains showed no significant changes in activity (Fig. 6d).
To improve biomass and delay autolysis of hosts, the fatty acid synthesis-related gene fabHB was integrated into the ydaP locus of DM6E2 strain, yielding the strain DM6E2△ydaPfabHB. In addition, the peptidoglycan degradation related gene lytD was deleted, generating the strain DM6E2△lytD (Fig. 6e). The AprE activities of these two strains reached 24,056 ± 947 U/mL and 22,882 ± 1474 U/mL, respectively, representing increases of 5.50% and 0.35% compared to the control strain DM6E2 (22,802 ± 792 U/mL) (Fig. 6e). Further biomass analysis showed that the overexpression of fabHB improved cell biomass (Fig. 6f), while deletion of lytD resulted in higher biomass and AprE activity when fermentation was extended to 54 h and 60 h (Fig. 6e–f).
3.5. Construction of a high-yield AprE-producing strain by modular engineering
Starting from the amino acid and energy supply-enhanced strain DM6E2 (DM6E-PylB-glyA-P43U12-ndk), we performed cell membrane and cell wall engineering. By sequentially integrating prsAbs expression, deleting pssA and integrating plsC expression, we obtained strains DM6E3 (DM6E2-nagB1P43U12-prsAbs), DM6E4 (DM6E3△pssA) and DM6E5 (DM6E4-Pbay-plsC) (Fig. 7a–b). The AprE activities of these strains were measured as 23,867 ± 716 U/mL, 25,309 ± 1379 U/mL and 26,233 ± 655 U/mL, respectively (Fig. 7c). Our results in Fig. 7d showed that, compared with DM6E3, the cation binding ratio of DM6E4 and DM6E5 increased by 15.05% and 11.00% respectively; the cell membrane permeability increased by 13.38% and 10.16%, respectively. Subsequently, lytD was deleted and fabHB was integrated into DM6E5. The AprE activity of DM6E7 strain (DM6E5△lytD△ydaPfabHB) reached 27,043 ± 492 U/mL, which was 3.09% higher than that of DM6E5, approximately 18.60% higher than that of DM6E3 (Fig. 7c). Besides, the biomass of DM6E6 (DM6E5△lytD) and DM6E7 strains showed a continuous increase (Fig. 7e). When the fermentation time was extended to 60 h, the AprE activity of DM6E7 reached 35,735 ± 1451 U/mL, which was 6.18% higher than that of DM6E5 (Fig. 7f).
Fig. 7.
Modular engineering for construction of a high-yield AprE-producing strain. a: Construction diagram of DM6E10 chassis host. b: Information on engineered strains. c: AprE activities of superimposed strains in cell membrane and cell wall module. d: The cell surface net negative charge and membrane permeability of strains DM6E3, DM6E4 and DM6E5. e: Biomass of DM6E3, DM6E4 and DM6E5 in TB medium. f: AprE activities. g: AprE activities of overflow metabolism engineering strains. h: Biomass. i: The intensities of oxalic acid, glycolate and glycine. j: Acetate concentrations. Data are represented as the means of three replicates and error bars represent standard deviations. *, P < 0.05; **, P < 0.01; ***, P < 0.001 indicate the significance levels between control and its mutant strains.
Then, the central metabolism overflow module was modified based on DM6E7, the oxdC gene was knocked out to obtain DM6E8 (DM6E7△oxdC). Compared with DM6E7, its AprE activity increased by 14.24%, reaching 30,896 ± 806 U/mL (Fig. 7g). Other physiological parameters showed that its biomass and by-product acetate concentration decreased, while glycine content increased (Fig. 7h–i). Since the weakening aceA had a better promoting effect on AprE activity in TB medium, DM6E9 (DM6E8-aceBTA) was constructed, and its AprE activity in AprE fermentation medium reached 32,831 ± 1084 U/mL (Figs. 4i and 7g). The glcDF gene was further enhanced to obtain strain DM6E10 (DM6E9-PbacA-glcDF), whose AprE activity reached 34,343 ± 1247 U/mL, approximately 27.00% higher than that of DM6E7 (Fig. 7g). Detection of organic carboxylic acids revealed that glycolate intensities in DM6E9 and DM6E10 were significantly reduced compared with those in DM6E8, while glycine intensities were increased (Fig. 7i). Furthermore, compared with DM6E7, the acetate content of DM6E8 showed a 58.39% reduction, and acetate contents of subsequently engineered strains DM6E9 and DM6E10 decreased progressively (Fig. 7j). This metabolic shift indicated enhanced glycolate consumption and carbon flux redirection toward the TCA cycle via acyl-CoA. Therefore, we obtained AprE high-yield host DM6E10 through modular engineering.
3.6. Fed-batch fermentation of AprE in a 5-L bioreactor
The strain DM6E10 was evaluated in a 5-L bioreactor for AprE fed-batch fermentation using a two-stage carbon source feeding strategy. The seed culture medium was inoculated at 10% (v/v) into the fermentation medium containing 30.0 g/L glucose. In the first stage, 150.0 mL of corn pulp (total mass 50.0 g) was added at 12 h and 24 h of fermentation, and the glucose concentration and biomass were monitored by sampling every 3 h. After the initial glucose was depleted, the second stage began, during which glucose was continuously fed to maintain a residual sugar concentration of approximately 15 g/L. When the OD600 exceeded 90, the carbon source was switched to 200.0 g of corn starch activated by α-amylase, and the entire fermentation process lasted 114 h. Process parameter monitoring showed that the biomass decreased at 36 h, followed by a secondary growth phase starting at 40 h, during which the biomass reached a peak of 159.4. The AprE activity slightly decreased at 40 h but ultimately achieved its maximum value of 107,100 ± 1671 U/mL at 108 h (Fig. 8).
Fig. 8.
Time profiles of AprE activitiy of strain DM6E10 in a 5 L bioreactor. Data are represented as the means of three replicates and error bars represent standard deviations. *, P < 0.05; **, P < 0.01; ***, P < 0.001 indicate the significance levels between control and its mutant strains.
4. Discussion
The global market size of industrial enzymes reached an estimated $7.42 billion in 2023, and is projected to continue its growth trajectory in the coming years, particularly within green manufacturing, biopharmaceutical and food industries. To meet the escalating demand, constructing efficient enzyme expression platforms via enzyme engineering and host modification has become a crucial strategy [36]. Current optimization approaches include codon optimization [37], increasing gene copy number [18], and enhancing expression elements [5] and secretion signal proteins [38]. As an excellent protein expression host, B. licheniformis is expected to be developed into a sustainable and robust cell factory. In this study, using AprE as a reporter protein, we systematically engineered efficient expression platforms for multiple secreted proteins in B. licheniformis DW2 by optimizing expression elements and cellular functional modules (Fig. 8). The relevant approaches not only improve protein expression levels but also provide valuable insights for advancing industrial enzyme production.
Subtle variations in codon preferences among phylogenetically close microorganisms are frequently overlooked [39]. In this study, we devised an evaluation scheme to identify restrictive codons. The application of this method to optimize the aprE gene resulted in a marked increase in its mRNA expression levels (Fig. 1b–c). Given that this method has not yet been validated on other proteins, subsequent work will assess its universality. In addition, other key factors such as the stability of RNA secondary structure, the accessibility of ribosome binding sites, and the translation-elongation rate can be comprehensively integrated to establish a more refined and universal codon optimization framework.
An ideal host chassis enables continuous cell growth, stable modular operation, and efficient overproduction of target products [40]. Streamlining non-essential metabolic pathways can reduce cellular metabolic burden and enhance product formation [41]. In this study, our reducted host chassis exhibited a remarkable 5.67-fold increase in AprE activity (Fig. 3c). Mechanism analysis revealed that the deletion of ccdA1 increased intracellular ATP concentration, decreased cytochrome c content, and affected the production of disulfide bond proteins (Unpublished). These findings suggest that CcdA1 may suppress the expression of disulfide bond proteins, thereby reducing competition for secreted proteins and ultimately enhancing target protein expression (Unpublished).
This study employed metabolomics to systematically identify metabolic bottlenecks limiting AprE expression. Interestingly, amino acid supplementation experiments revealed that glycine addition was the most effective in enhancing AprE activity, rather than threonine, which exhibited the most pronounced changes in the metabolomic profile (Fig. 4a–b). We hypothesized that this outcome may be attributed to the broader physiological roles of glycine [32]. Subsequently, AprE activity was progressively enhanced through rational engineering transformation, including strengthening the supply of synthesis precursors, modifying the cell membrane and cell wall, and reducing central metabolic overflow. However, catabolite repression persisted during actual fermentation, indicating a need for further rational reconstruction of the host's transcriptional regulatory network [42]. Furthermore, future research will focus on the combinatorial module assembly and precise gene regulation to optimize synergistic interactions between modules. It is envisaged that the implementation of a genome-scale metabolic network (GSMN)-guided digital design platform will substantially accelerate the realization of these aims [43].
In conclusion, this study established universally applicable expression elements and reducted hosts, achieving 5.77-fold, 4.84-fold, and 1.31-fold enhancement in alkaline protease, nattokinase and chitinase activities, respectively. By combining metabolomics analysis with modular engineering, we systematically optimized precursor supply, modified the cell membrane and cell wall, and reduced central metabolism overflow in the AprE expression host. This comprehensive engineering approach yielded host DM6E10 with a final AprE activity of 34,343 ± 1247 U/mL, representing a 110% increase over DM6E (16,349 ± 316 U/mL). Scale-up in a 5 L bioreactor further elevated production to 107,100 ± 1671 U/mL, which is highly competitive in industrialization [44]. In summary, these strategies establish a high-performance B. licheniformis cell factory for recombinant protein expression.
Data availability
Data will be made available on request.
CRediT authorship contribution statement
Qing Zhang: Conceptualization, Formal analysis, Investigation, Methodology, Writing – original draft. Mengyuan Zhang: Methodology. Zhihao Zhu: Data curation. Haijing Ma: Software. Fei Mo: Methodology. Jiaqi Lei: Data curation. Shisi He: Investigation. Yongqing Liao: Software. Shihao Yan: Methodology. Dongbo Cai: Resources, Writing – review & editing. Shouwen Chen: Funding acquisition, Project administration, Supervision.
Declaration of competing interest
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Acknowledgements
This work was funded by the Science and Technology Innovation Talent Program of Hubei Province (2024DJA022), and Technological Innovation Program Project of Hubei Province (2024BBB066), and the Special Zone Project of Wuhan Natural Science Foundation (2024040701010048).
Footnotes
Peer review under the responsibility of Editorial Board of Synthetic and Systems Biotechnology.
Supplementary data to this article can be found online at https://doi.org/10.1016/j.synbio.2026.07.005.
Contributor Information
Dongbo Cai, Email: caidongbo@hubu.edu.cn.
Shouwen Chen, Email: mel212@126.com.
Appendix A. Supplementary data
The following is the Supplementary data to this article:
References
- 1.Matkawala F., Nighojkar S., Kumar A., Nighojkar A. Microbial alkaline serine proteases: production, properties and applications. World J Microbiol Biotechnol. 2021;37:63. doi: 10.1007/s11274-021-03036-z. [DOI] [PubMed] [Google Scholar]
- 2.Grand View Research . 2023. Industrial enzymes market size, share, growth report, 2030.https://www.grandviewresearch.com/industry-analysis/industrial-enzymes-market [Google Scholar]
- 3.Cai D., Rao Y., Zhan Y., Wang Q., Chen S. Engineering Bacillus for efficient production of heterologous protein: current progress, challenge and prospect. J Appl Microbiol. 2019;126:1632–1642. doi: 10.1111/jam.14192. [DOI] [PubMed] [Google Scholar]
- 4.Fu Y., Rao Y., Liao Y., Zhang Q., Ma X., Cai D., Chen S. Protein engineering, expression optimization, and application of alkaline protease from Alkalihalobacillus clausii FYX. Int J Biol Macromol. 2025;307 doi: 10.1016/j.ijbiomac.2025.141891. [DOI] [PubMed] [Google Scholar]
- 5.Li J., Jiang L., Cao X., Wu Y., Lu F., Liu F., Li Y., Liu Y. Improving the activity and stability of Bacillus clausii alkaline protease using directed evolution and molecular dynamics simulation. Enzym Microb Technol. 2021;147 doi: 10.1016/j.enzmictec.2021.109787. [DOI] [PubMed] [Google Scholar]
- 6.Grahame D.A.S., Dupuis J.H., Bryksa B.C., Tanaka T., Yada R.Y. Improving the alkaline stability of pepsin through rational protein design using renin, an alkaline-stable aspartic protease, as a structural and functional reference. Enzym Microb Technol. 2021;150 doi: 10.1016/j.enzmictec.2021.109871. [DOI] [PubMed] [Google Scholar]
- 7.Van Tilburg A., Warmer P., Van Heel A., Sauer U., Kuipers O. Membrane composition and organization of Bacillus subtilis 168 and its genome‐reduced derivative mini Bacillus PG10. Microb Biotechnol. 2022;15:1633–1651. doi: 10.1111/1751-7915.13978. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Sun X., Xue X., Li M., Gao F., Hao Z., Huang H., Luo H., Qin L., Yao B., Su X. Efficient coproduction of mannanase and cellulase by the transformation of a codon-optimized endomannanase gene from Aspergillus niger into Trichoderma reesei. J Agric Food Chem. 2017;65:11046–11053. doi: 10.1021/acs.jafc.7b05114. [DOI] [PubMed] [Google Scholar]
- 9.Peng Z., Zhang J., Song Y., Guo R., Du G., Chen J. Engineered pro‐peptide enhances the catalytic activity of keratinase to improve the conversion ability of feather waste. Biotechnol Bioeng. 2021;118:2559–2571. doi: 10.1002/bit.27771. [DOI] [PubMed] [Google Scholar]
- 10.Zhang J., Xu X., Li X., Chen X., Zhou C., Liu Y., Li Y., Lu F. Reducing the cell lysis to enhance yield of acid-stable alpha amylase by deletion of multiple peptidoglycan hydrolase-related genes in Bacillus amyloliquefaciens. Int J Biol Macromol. 2021;167:777–786. doi: 10.1016/j.ijbiomac.2020.11.193. [DOI] [PubMed] [Google Scholar]
- 11.Zhou C., Zhou H., Li D., Zhang H., Wang H., Lu F. Optimized expression and enhanced production of alkaline protease by genetically modified Bacillus licheniformis 2709. Microb Cell Fact. 2020;19:45. doi: 10.1186/s12934-020-01307-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Zhu J., Cai D., Xu H., Liu Z., Zhang B., Wu F., Li J., Chen S. Enhancement of precursor amino acid supplies for improving bacitracin production by activation of branched chain amino acid transporter BrnQ and deletion of its regulator gene lrp in Bacillus licheniformis. Synth Syst Biotechnol. 2018;3:236–243. doi: 10.1016/j.synbio.2018.10.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Mo F., Cai D., He P., Yang F., Chen Y., Ma X., Chen S. Enhanced production of heterologous proteins via engineering the cell surface of Bacillus licheniformis. J Ind Microbiol Biotechnol. 2019;46:1745–1755. doi: 10.1007/s10295-019-02229-8. [DOI] [PubMed] [Google Scholar]
- 14.Cao H., Van Heel A.J., Ahmed H., Mols M., Kuipers O.P. Cell surface engineering of Bacillus subtilis improves production yields of heterologously expressed α-amylases. Microb Cell Fact. 2017;16:56. doi: 10.1186/s12934-017-0674-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Chen J., Fu G., Gai Y., Zheng P., Zhang D., Wen J. Combinatorial sec pathway analysis for improved heterologous protein secretion in Bacillus subtilis: identification of bottlenecks by systematic gene overexpression. Microb Cell Fact. 2015;14:92. doi: 10.1186/s12934-015-0282-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Zhang J., Zhu B., Li X., Xu X., Li D., Zeng F., Zhou C., Liu Y., Li Y., Lu F. Multiple modular engineering of Bacillus amyloliquefaciens cell factories for enhanced production of alkaline proteases from B. clausii. Front Bioeng Biotechnol. 2022;10 doi: 10.3389/fbioe.2022.866066. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Cai D., Zhu C., Chen S. Microbial production of nattokinase: current progress, challenge and prospect. World J Microbiol Biotechnol. 2017;33:84. doi: 10.1007/s11274-017-2253-2. [DOI] [PubMed] [Google Scholar]
- 18.Zhou C., Yang G., Zhang L., Zhang H., Zhou H., Lu F. Construction of an alkaline protease overproducer strain based on Bacillus licheniformis 2709 using an integrative approach. Int J Biol Macromol. 2021;193:1449–1456. doi: 10.1016/j.ijbiomac.2021.10.208. [DOI] [PubMed] [Google Scholar]
- 19.Wei X., Zhou Y., Chen J., Cai D., Wang D., Qi G., Chen S. Efficient expression of nattokinase in Bacillus licheniformis: host strain construction and signal peptide optimization. J Ind Microbiol Biotechnol. 2015;42:287–295. doi: 10.1007/s10295-014-1559-4. [DOI] [PubMed] [Google Scholar]
- 20.Wang S., Zhu J., Zhao Y., Mao S., He Y., Wang F., Jia T., Cai D., Chen J., Wang D., Chen S. Developing a Bacillus licheniformis platform for de novo production of γ-aminobutyric acid and other glutamate-derived chemicals. Metab Eng. 2025;88:124–136. doi: 10.1016/j.ymben.2024.12.010. [DOI] [PubMed] [Google Scholar]
- 21.Zhan Y., Shi J., Xiao Y., Zhou F., Wang H., Xu H., Li Z., Yang S., Cai D., Chen S. Multilevel metabolic engineering of Bacillus licheniformis for de novo biosynthesis of 2-phenylethanol. Metab Eng. 2022;70:43–54. doi: 10.1016/j.ymben.2022.01.007. [DOI] [PubMed] [Google Scholar]
- 22.Yuan H., Xu Y., Chen Y., Zhan Y., Wei X., Li L., Wang D., He P., Li S., Chen S. Metabolomics analysis reveals global acetoin stress response of Bacillus licheniformis. Metabolomics. 2019;15:25. doi: 10.1007/s11306-019-1492-7. [DOI] [PubMed] [Google Scholar]
- 23.Zhang Q., Zhu W., He S., Lei J., Xu L., Hu S., Zhang Z., Cai D., Chen S. Understanding energy fluctuation during the transition state: the role of AbrB in Bacillus licheniformis. Microb Cell Fact. 2024;23:296. doi: 10.1186/s12934-024-02572-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Wang D., Zhan Y., Cai D., Li X., Wang Q., Chen S. Regulation of the synthesis and secretion of the iron chelator cyclodipeptide pulcherriminic acid in Bacillus licheniformis. Appl Environ Microbiol. 2018;84 doi: 10.1128/AEM.00262-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Zhan Y., Zhou M., Wang H., Chen L., Li Z., Cai D., Wen Z., Ma X., Chen S. Efficient synthesis of 2-phenylethanol from L-phenylalanine by engineered Bacillus licheniformis using molasses as carbon source. Appl Microbiol Biotechnol. 2020;104:7507–7520. doi: 10.1007/s00253-020-10740-7. [DOI] [PubMed] [Google Scholar]
- 26.Wang S., Wang H., Zhang D., Li X., Zhu J., Zhan Y., Cai D., Wang Q., Ma X., Wang D., Chen S. Multistep metabolic engineering of Bacillus licheniformis to improve pulcherriminic acid production. Appl Environ Microbiol. 2020;86 doi: 10.1128/AEM.03041-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Cai D., Wei X., Qiu Y., Chen Y., Chen J., Wen Z., Chen S. High-level expression of nattokinase in Bacillus licheniformis by manipulating signal peptide and signal peptidase. J Appl Microbiol. 2016;121:704–712. doi: 10.1111/jam.13175. [DOI] [PubMed] [Google Scholar]
- 28.Qin X., Xin Y., Su X., Wang X., Zhang J., Tu T., Wang Y., Yao B., Huang H., Luo H. Heterologous expression and characterization of thermostable chitinase and β-N-acetylhexosaminidase from Caldicellulosiruptor acetigenus and their synergistic action on the bioconversion of chitin into N-acetyl-d-glucosamine. Int J Biol Macromol. 2021;192:250–257. doi: 10.1016/j.ijbiomac.2021.09.204. [DOI] [PubMed] [Google Scholar]
- 29.Rao Y., Wang J., Yang X., Xie X., Zhan Y., Ma X., Cai D., Chen S. A novel toolbox for precise regulation of gene expression and metabolic engineering in Bacillus licheniformis. Metab Eng. 2023;78:159–170. doi: 10.1016/j.ymben.2023.06.004. [DOI] [PubMed] [Google Scholar]
- 30.Yamamoto J., Chumsakul O., Toya Y., Morimoto T., Liu S., Masuda K., Kageyama Y., Hirasawa T., Matsuda F., Ogasawara N., Shimizu H., Yoshida K., Oshima T., Ishikawa S. Constitutive expression of the global regulator AbrB restores the growth defect of a genome-reduced Bacillus subtilis strain and improves its metabolite production. DNA Res. 2022;29:1–13. doi: 10.1093/dnares/dsac015. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Dong H., Sharma M., Zhou H.-X., Cross T.A. Glycines: role in α-helical membrane protein structures and a potential indicator for native conformation. Biochemistry. 2012;51:4779–4789. doi: 10.1021/bi300090x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Bouzon M., Perret A., Loreau O., Delmas V., Perchat N., Weissenbach J., Taran F., Marlière P. A synthetic alternative to canonical one-carbon metabolism. ACS Synth Biol. 2017;6:1521–1533. doi: 10.1021/acssynbio.7b00029. [DOI] [PubMed] [Google Scholar]
- 33.Wani Lako J., Yengkopiong J., Stafford W., Tuffin M., Cowan D. Cloning, expression and characterization of thermostable YdaP from Bacillus licheniformis 9A. Acta Biochim Pol. 2018;65:59–66. doi: 10.18388/abp.2017_1499. [DOI] [PubMed] [Google Scholar]
- 34.Yang S., Song L., Wang J., Zhao J., Tang H., Bao X. Engineering Saccharomyces cerevisiae for efficient production of recombinant proteins. Eng Microbiol. 2023;4 doi: 10.1016/j.engmic.2023.100122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Tojo S., Satomura T., Matsuoka H., Hirooka K., Fujita Y. Catabolite repression of the Bacillus subtilis FadR regulon, which is involved in fatty acid catabolism. J Bacteriol. 2011;193:2388. doi: 10.1128/JB.00016-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Yang L., Shi H., Liu F., Wang Z., Chen K., Chen W., Niu X., Kan Y., Yao L., Tang C. Gene cloning of a highly active phytase from Lactobacillus plantarum and further improving its catalytic activity and thermostability through protein engineering. Enzym Microb Technol. 2022;156 doi: 10.1016/j.enzmictec.2022.109997. [DOI] [PubMed] [Google Scholar]
- 37.Gong B., Mao R., Xiao Y., Jia M., Zhong X., Liu Y., Xu P., Li G. Improvement of enzyme activity and soluble expression of an alkaline protease isolated from oil-polluted mud flat metagenome by random mutagenesis. Enzym Microb Technol. 2017;106:97–105. doi: 10.1016/j.enzmictec.2017.06.015. [DOI] [PubMed] [Google Scholar]
- 38.Kang Z., Yang S., Du G., Chen J. Molecular engineering of secretory machinery components for high-level secretion of proteins in Bacillus species. J Ind Microbiol Biotechnol. 2014;41:1599–1607. doi: 10.1007/s10295-014-1506-4. [DOI] [PubMed] [Google Scholar]
- 39.Quax T., Claassens N., Söll D., van der Oost J. Codon bias as a means to fine-tune gene expression. Mol Cell. 2015;59:149–161. doi: 10.1016/j.molcel.2015.05.035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Qin J., Zhou Y., Krivoruchko A., Huang M., Liu L., Khoomrung S., Siewers V., Jiang B., Nielsen J. Modular pathway rewiring of Saccharomyces cerevisiae enables high-level production of L-ornithine. Nat Commun. 2015;6:8224. doi: 10.1038/ncomms9224. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Ma S., Su T., Lu X., Qi Q. Bacterial genome reduction for optimal chassis of synthetic biology: a review. Crit Rev Biotechnol. 2023:1–14. doi: 10.1080/07388551.2023.2208285. [DOI] [PubMed] [Google Scholar]
- 42.Zhang Y., Li Y., Xiao F., Wang H., Zhang L., Ding Z., Xu S., Gu Z., Shi G. CcpA mutants influence selective carbon source utilization by changing interactions with target genes in Bacillus licheniformis. Syst Microbiol Biomanuf. 2022;2:193–207. doi: 10.1007/s43393-021-00055-7. [DOI] [Google Scholar]
- 43.Qian J., Wang Y., Liu X., Hu Z., Xu N., Wang Y., Shi T., Ye C. Improving acetoin production through construction of a genome-scale metabolic model. Comput Biol Med. 2023;158 doi: 10.1016/j.compbiomed.2023.106833. [DOI] [PubMed] [Google Scholar]
- 44.Zhang Y., Liu Z., Hu J., Yao Q., Xu H., Zhang Q., Chen S., Wang Y. Elucidating metabolic mechanisms underlying the influence of specific growth rate on alkaline protease synthesis in Bacillus licheniformis through combined omics and computational modeling analysis. Bioresour Technol. 2025 doi: 10.1016/j.biortech.2025.132762. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
Data will be made available on request.








